1. Background {#sec0005}
=============

*Stenotrophomonas maltophilia* (*S. maltophilia*) is a nonfermentative, gram-negative, aerobic bacillus that is widely distributed in the nature. In a hospital setting, it has been found in water-related sources and contaminated medical equipments.[@bib0090], [@bib0095], [@bib0100] Although *S. maltophilia* is not highly virulent, its treatment is challenging because of its resistance to multiple antibiotics. Therefore, the relentless progression of patient\'s underlying illness adds to higher causalities.[@bib0105], [@bib0110], [@bib0115], [@bib0120] Infective endocarditis due to *S. maltophilia* is very rare. Only 41 cases have been reported so far worldwide, most of which required surgical treatment. In this report, we share our experience of two cases of infective endocarditis managed by culture-sensitive antibiotics.

2. Case report {#sec0010}
==============

2.1. Case 1 {#sec0015}
-----------

A 35-year-old man was admitted to our hospital 3 months back with history of fever with chills for five days. The patient had undergone PBMV for severe rheumatic mitral stenosis 2 weeks prior to this episode. No other predisposition was found. There was no history of dental procedures or injections of intravenous drugs. On physical examination, blood pressure was 110/70 mmHg, pulse rate 85/min, and body temperature of 38 °C. Cardiac examination revealed loud S1 and P2 with grade III mid-diastolic murmur at the apex. The remaining physical examination was unremarkable. There were no peripheral signs of infective endocarditis. Laboratory tests showed that his Hemoglobin was 12.8 gm/dl, white blood cell (WBC) was 18,900/L, erythrocyte sedimentation rate (ESR) was 52 mm in first hour, and urinalysis was normal. Renal parameters were normal. Cardiomegaly was apparent in chest radiography.[@bib0145] Electrocardiogram revealed a normal sinus rhythm. The transthoracic echo demonstrated moderate mitral stenosis, severe eccentric mitral regurgitation, which was not there previously, and suspicious vegetation was present on mitral valve. The transesophagial echocardiogram revealed freely mobile sessile vegetation of size 5 mm × 5 mm over both anterior and posterior mitral leaflets ([Fig. 1](#fig0005){ref-type="fig"}). The patient was started with a regimen of ceftriaxone and gentamycin. *S. maltophilia* was identified on blood culture and the antibiotics were changed to co-trimoxazole and levofloxacin as per culture sensitivity report. After 1 week of antibiotics, patient became afebrile, and repeat transesophagial echo after 2 weeks revealed disappearance of vegetation ([Fig. 2](#fig0010){ref-type="fig"}). Antibiotics were continued for 6 weeks. He was discharged successfully.

2.2. Case 2 {#sec0020}
-----------

A 40-year-old man was admitted for fever and chill for a period of 2 months following mechanical valve replacement (27 mm Carbo-Medics) of mitral valve for severe rheumatic mitral stenosis. No other comorbidities were found. There was no history of dental procedures or injections of intravenous drugs. At presentation, he was drowsy, pale, and edematous with raised jugular venous pulsation. Blood pressure was 90/60 mmHg, pulse rate 120/min, and body temperature was 38 °C. Cardiac examination revealed soft S1, normal S2 with metallic heart sound. There was no audible murmur. Chest examination revealed bilateral basal crepitations. Glasgow Coma Scale (GCS) at presentation was E3 M5 V4 with no focal neurological deficits. The rest of the physical examination was unremarkable. Laboratory tests showed that Hb was 7.6 gm/dl, WBC 17,500/L, and ESR was 80 mm/hr. The renal parameters were elevated with urea of 65 mg/dl and serum creatinine of 3.0 mg/dl. Arterial Blood Gas (ABG) revealed metabolic acidosis. Increased cardiothoracic ratio and features suggestive of pulmonary edema were observed on chest radiography. Electrocardiogram revealed sinus tachycardia. The transthoracic echo demonstrated large mobile vegetation of 2 cm × 1.6 cm in size on prosthetic mitral valve ([Fig. 3](#fig0015){ref-type="fig"}). There was mild paravalvular leak with partial dehiscence, moderate mitral regurgitation, moderate tricuspid valve regurgitation, moderate pulmonary arterial hypertension, and moderate left ventricular dysfunction. The patient was empirically started on vancomycin and ceftriaxone. Initially, blood cultures grew MRSA sensitive to only teicoplanin, gentamycin, and linezolid. Fever continued with spikes. Supportive treatment was given in the form of inotropic support, vasodilators, and peritoneal dialysis for rapidly worsening renal dysfunction. By the time, the repeat blood culture could identify the culprit bacteria to be *S. maltophilia*, the patient died of septicemia and renal dysfunction.

3. Discussion {#sec0025}
=============

We share the challenges in managing two cases of *S. maltophilia* endocarditis of different outcomes. One patient was managed successfully with culture-guided early antibiotic therapy, while other case succumbed before the arrival of culture report.

*S. maltophilia* endocarditis is a rare disease. Only 41 cases have been reported around the world before our observations ([Table 1](#tbl0005){ref-type="table"}). The clinical features vary from case to case. In-hospital habitat is the reservoir. *S. maltophilia* endocarditis is likely to develop under specific conditions, such as the use of central venous lines, prior cardiac surgery, and intravenous drug abuse.[@bib0105], [@bib0110], [@bib0115], [@bib0120] Thus, *S. maltophilia* from contaminated medical equipment in hospitals may cause endocarditis when the skin barrier is broken.[@bib0095], [@bib0115] In particular, prior valve replacement is one of the predisposing factors that accounts for approximately 40--60% of the endocarditis cases.[@bib0110], [@bib0115], [@bib0120]

Treatment of endocarditis caused by *S. maltophilia* comprises appropriate antibiotic therapy and removal of indwelling infected foreign material in the body. Because of limited experience and resistance to multiple antibiotics, the treatment is purely based on consensus and regional culture sensitivity pattern. *S. maltophilia* is resistant to penicillin, cephalosporin, and Carbapenems. Sulfamethoxazole-trimethoprim is selected as the first-line antibiotic, supported by in vitro susceptibility.[@bib0095], [@bib0100] Since sulfamethoxazole-trimethoprim is bacteriostatic against the most isolates, it is used in combination with other antibiotics for synergistic effect. The difficulty in treating *S. maltophilia* endocarditis with antibiotic therapy arises due to sulfamethoxazole-trimethoprim intolerance. Several reports have stated that combination therapy with fluoroquinolones, aminoglycosides, and 3rd or 4th generation cephalosporin is effective.[@bib0115], [@bib0125] Discrepancies between the in vitro susceptibility data and clinical outcome have been noted in the case of *S. maltophilia* infections.[@bib0090], [@bib0100] Both morbidity and mortality rates are high in cases of endocarditis caused by *S. maltophilia*. The overall incidence of mortality is approximately 34.8% (15/43), as has been summarized from case reports around the world ([Table 1](#tbl0005){ref-type="table"}). Complications such as cerebral vascular disease, congestive heart failure, and organic abscess are seen in 70--80% of patients[@bib0110], [@bib0115], [@bib0120] because of antibiotic resistance. Autoimmunity could be included as a novel predisposing factor for *S. maltophilia* endocarditis, as reported in case report by Carrillo-Córdova et al.[@bib0170] Until now, to the best of our knowledge, there is no published report of infective endocarditis caused by *S. maltophilia* from Indian subcontinent.

4. Conclusion {#sec0030}
=============

The true epidemiological profile of infective endocarditis due to *S. maltophilia* is emerging. The treatment for this organism has not been addressed in most recently updated infective endocarditis guidelines. The very reason may be its rare occurrence and paucity of experience. It is important to identify this microorganism as quickly as possible, since *S. maltophilia* is resistant to first line antibiotic therapy generally used in case of nosocomial infections. This case report reemphasizes the meticulous steps in the prevention of device-related infections in operation theaters and cardiac catheterization laboratories. These are the first two case reports of infective endocarditis caused by *S. maltophilia* from India.
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![Transesophagial echocardiography (TEE) image is showing two mobile vegetations over anterior and posterior mitral leaflet before treatment of case number one.](gr1){#fig0005}

![Transesophagial echocardiography (TEE) image is showing disappearance of vegetation after 2 weeks of culture sensitive-based antibiotic regimen of case one.](gr2){#fig0010}

![Transesophagial echocardiography (TEE) image is showing mobile vegetation over prosthetic mitral leaflet of case 2 who died in hospital.](gr3){#fig0015}

###### 

The brief summary of worldwide experience of *Stenotrophomonas maltophilia* infectious endocarditis.

  Case     Ref.         Clinical profile   Management                                                         Complications         Outcomes                                                                                                      
  -------- ------------ ------------------ ------------------------------------------------------------------ --------------------- ---------------------------------- ----- -------------------------------------------------------------------- ----
  1        [@bib0130]   26/M               Recent valve replacement (\<1 month)                               PMV, ASD patch        CHL, KAN, COL                      Yes   Multiple septic emboli                                               D
  2        [@bib0130]   30/M               Recent valve replacement (\<1 month)                               PMV, ASD patch        CHL                                No    None                                                                 C
  3        [@bib0130]   65/F               Cystoscopy, valve replacement (7 months)                           PMV                   CAR, GEN, KAN, CHL, PEN, POL       Yes   Persistent bacteremia                                                C
  4        [@bib0130]   35/M               Recent valve replacement (early), rheumatic carditis               PMV                   CAR, GEN, SXT                      No    None                                                                 C
  5        [@bib0130]   38/M               None                                                               PMV                   STR, PEN                           No    Septic emboli, MI                                                    D
  6        [@bib0130]   22/M               IVDU                                                               PAV                   CAR, AMK, SXT                      Yes   CHF, septic emboli                                                   C
  7        [@bib0130]   31/F               IVDU, dental treatment                                             PAV                   CAR, KAN, SXT                      Yes   Perivalvular abscess                                                 C
  8        [@bib0130]   57/M               IVDU, rheumatic carditis                                           NAV, NMV              POL, SXT                           No    Septic emboli                                                        C
  9        [@bib0130]   25/M               None                                                               VSD repair            GEN, CHL                           No    NR                                                                   D
  10       [@bib0130]   33/M               IVDU, aortic stenosis, atrial fistula                              NAV, NTV              TIC, MOX, SXT                      Yes   CHF, myocardial abscess                                              D
  11       [@bib0130]   NR                 CVC                                                                NTV                   NR                                 NR    NR                                                                   D
  12       [@bib0130]   NR                 NR                                                                 NAV                   NR                                 NR    NR                                                                   D
  13       [@bib0130]   NR                 CVC                                                                NAV                   NR                                 NR    NR                                                                   C
  14       [@bib0130]   33/M               IVDU, dental treatment                                             PAV                   SXT, AMC, GEN                      Yes   Perivalvular abscess                                                 C
  15       [@bib0130]   56/M               Recent valve replacement (early)                                   PAV                   CAZ, GEN, SXT                      Yes   Septic emboli                                                        D
  16       [@bib0130]   32/M               IVDU, subcutaneous reservoir                                       NTV                   SXT                                No    CHF                                                                  D
  17       [@bib0130]   28/M               IVDU                                                               NAV                   CIP, GEN                           Yes   Myocardial abscess                                                   C
  18       [@bib0130]   60/F               Ventriculo-atrial shunt                                            NTV                   TIM, SXT                           No    Lung abscess                                                         C
  19       [@bib0130]   36/M               Dental treatment (3 months)                                        NAV                   TZP, GEN                           Yes   CHF                                                                  C
  20       [@bib0130]   69/F               Recent valve replacement (3 months)                                PMV, PAV              CAZ, GEN, CIP, SXT                 Yes   CHF, persistent bacteremia                                           D
  21       [@bib0135]   37/M               Recent mitral valvuloplasty (early)                                PMV                   CAZ, AMK, CIP then TIM, SXT, COL   Yes   None                                                                 C
  22       [@bib0130]   58/F               Recent valve replacement (3 months)                                PMV                   SXT                                Yes   None                                                                 C
  23       [@bib0130]   62/M               Recent valve replacement (6 months)                                PAV                   CIP, CHL                           No    Aortic dissection                                                    C
  24       [@bib0130]   40/M               Recent valve replacement (9 months)                                PAV                   TIM, SXT                           No    None                                                                 C
  25       [@bib0130]   44/M               Rheumatic valvular disease                                         PMV                   VAN, GEN                           No    Recurrence with septic emboli treated by TMP-SMZ + TOB and surgery   C
  26       [@bib0140]   44/M               IVDU, HIV, dental treatment, rheumatic aortic and mitral disease   NMV, NAV              LVX, SXT                           No    None                                                                 C
  27       [@bib0130]   56/F               CVC                                                                NAV                   FEP, CIP, SXT                      No    None                                                                 C
  28       [@bib0145]   65/F               NR                                                                 PAV                   NR                                 NR    CHF, paravalvular abscess                                            NA
  29       [@bib0120]   34/F               Peripheral catheter                                                PMV                   SXT, GEN                           No    None                                                                 C
  30       [@bib0150]   38/M               Recent valve replacement (1 year)                                  PAV                   SXT, TIM                           Yes   Subannular abscess                                                   C
  31       [@bib0155]   28/M               Recent valve replacement (3 weeks)                                 PAV                   SXT, CAZ                           Yes   None                                                                 C
  32       [@bib0160]   --                 Pacemaker                                                          Pacemaker pocket      --                                 Yes   None                                                                 C
  33--39   [@bib0125]   68--84             Recent valve replacement                                           PAV                   CAZ                                Yes   CNS complications in 4                                               3D
  40       [@bib0165]   78/F               None                                                               PMV                   SXT, CIP, TZP                      Yes   Multiple cerebral infarction and paravalvular abscess                D
  41       [@bib0170]   23/F               Autoimmunity related to SLE                                                                                                                                                                            
  42       Case 1       35/M               Rheumatic heart disease                                            Native mitral valve   SXT, LVX                           No    None                                                                 C
  43       Case 2       40/M               Recent valve replacement (4 months)                                PMV                   VAN, GEN                           No    Renal failure                                                        D

Out of 43 cases, 14 patients (33%) died out of various complications.

*Abbreviations*: AMC, ampicillin; AMK, amikacin; ASD, atrial septal defect; CAR, carbenicillin; CAZ, ceftazidime; CHF, congestive heart failure; CHL, chloramphenicol; CIP, ciprofloxacin; COL, colistin; CVC, central venous catheter; FEP, cefepime; GEN, gentamicin; IVDU, intravenous drug user; KAN, kanamycin; LVX, levofloxacin; MI, myocardial infarction; MOX, moxalactam; NAV, natural aortic valve; NMV, natural mitral valve; NR, not reported; PAV, prosthetic aortic valve; PEN, penicillin; PMV, prosthetic mitral valve; POL, polymyxin; PR, present report; STR, streptomycin; SXT, trimethoprim-sulfamethoxazole; TIC, ticarcillin; TIM, ticarcillin-clavulanic acid; TOB, tobramycin; TZP, piperacillin-tazobactam; VAN, vancomycin; VSD, ventricular septal defect. D, died; C, cure; MM, medical management; SLE, systemic lupus erythematous.
